Mitral valve regurgitation (leakage) is one of the very common heart diseases. It is estimated that around 25 million patients worldwide suffer from it. CoreMedic GmbH has developed the ChordArt™ mitral valve repair system, a device for the safe repair of the mitral valve. In a broad, two-year patient study, the ChordArt™ system has now been able to prove its effectiveness and safety, as shown by the data published in the Journal of Thoratic and Cardiovascular Surgery on 29.10.2021 as a PreProof study.
More information: https://www.coremedic.de/news-resources